On 7 September, the European Federation of Pharmaceutical Industries and Associations (EFPIA) held an event under the banner “Unlocking tomorrow’s cures” in Brussels, Belgium. The EFPIA Rentrée 2017 gathered six scientists working on groundbreaking, innovative and life-changing therapies: Dr Frank Bähner, Area Head Prophylactic Vaccines at Curevac, explained the advantages of mRNA vaccines where pandemics…
On 31 July, The Times Scotland published an article entitled: “Everyday pill to stop dementia in its tracks is tested in Scotland” where the EPAD project was featured. In this great article wrote by Helen Puttick, the health reporter for The Times in Scotland, Prof Craig Ritchie, EPAD co-coordinator, explained dementia prevention and mentioned that…
What is your current role in EPAD? I am a biostatistician and therefore my key role is in the statistical work package (WP2). I have mostly been involved in writing the protocol for the proof-of-concept study, which has been evolving since I joined EPAD in February 2016. WP2 is also responsible for statistical modelling of…
What is your current role in EPAD? I work as a clinical project manager in the Gérontopôle team at Toulouse University Hospital coordinated by Pr Bruno Vellas who is the EPAD National Lead for France. I was designated to be the national study coordinator for EPAD project in 2015. We are involved in two major…
The European Prevention of Alzheimer’s Dementia Consortium (EPAD) seeks a Global Trial Leader. There have been no new treatments for Alzheimer’s Dementia for over 15 years and there are no interventions on the market at all for disease modification or prevention. EPAD is the world’s largest ever dedicated platform for testing new interventions to prevent…
EPAD is establishing a Europe-wide cohort of over 6,000 participants, of which 1,500 will be invited to participate in a trial to test new treatments for prevention of Alzheimer’s dementia. The EPAD Longitudinal Cohort Study (EPAD-LCS) opened for recruitment in May 2016. It is a core part of the EPAD project that links participants in…
The EPAD consortium is increasing in optimism regarding the success of its project that had some great media coverage during the summer. On 20 July, research in dementia prevention was covered in BBC on its main 6 o’clock news bulletin (see link at bottom – from 19 min 50 sec) and on BBC Radio 4…
The European Prevention of Alzheimer’s Dementia (EPAD) project launched its second video about amyloid. This animation movie tries to explain what we currently understand about amyloid and how it relates to dementia. EPAD Research Participants may be invited to take part in a clinical trial if test results suggest abnormal levels of a protein called…
On June 24-27, the third Congress of the European Academy of Neurology (EAN) took place in Amsterdam. The congress gathered more than 6,000 neurologists from all over Europe and the rest of the world. Our WP6 co-leader Sean Knox attended the event. He presented the EPAD project in a great interview with Touch Neurology. He…
We are very pleased to announce that the EPAD LCS study is now recruiting volunteers in San Sebastian (Spain), which opened as a new EPAD Trial Delivery Center. This centre is the first wave 2 centres opened and few other will be following very soon. Aranzazu is the first participant enrolled in the EPAD project…
